Every community pharmacy will be impacted by the negative hit to dispensing remuneration. Yet not all can benefit from its reallocation to programs. This is partly because it is mostly a commitment to remunerate pharmacies for what they are already doing or to displace non-PBS revenue with official remuneration.
Report confirms negative impact and highlights the risk of unintended consequences
June 8, 2023 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Most Australians want PBS medicine prices frozen or cut, poll finds
October 30, 2026 - - Latest News -
Canberra program shows young women where a future in health could take them
October 30, 2026 - - Latest News -
If only these patients needed a Spoodle, rather than a medicine
October 30, 2026 - - Latest News -
A hearing that provided more evidence of the need for meaningful change
October 29, 2026 - - Latest News -
Biotech sector warns R&D tax changes could drive clinical trials offshore
October 28, 2026 - - Latest News -
Rebates and net spend are the major PBS story of the past decade
October 28, 2026 - - Latest News -
Astellas bets up to US$1.34 billion on Melbourne startup's cancer candidate
October 28, 2026 - - Latest News
